Literature DB >> 8592359

Lyssavirus in Eptesicus serotinus (Chiroptera: Vespertilionidae).

J L Pérez-Jordá1, C Ibánez, M Muñoz-Cervera, A Téllez.   

Abstract

To determine the prevalence of European Bat Lyssavirus 1 (EBL1), antibodies plasma samples were obtained from 175 serotine bats (Eptesicus serotinus) from four colonies in southern Spain between September of 1991 and September 1992. Five bats were detected with EBL1 virus in one colony in 1989. The prevalence of antibodies rose to 74% in one of the colonies studied (Villarrasa) in the spring of 1992. After a few months the prevalence declined to under 10%. Individuals with a high antibody level in the spring (up to ED50 = 280) had very low titers or no antibodies in the following summer and autumn.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592359     DOI: 10.7589/0090-3558-31.3.372

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  11 in total

1.  Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs.

Authors:  J E Echevarría; A Avellón; J Juste; M Vera; C Ibáñez
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  European bat lyssavirus infection in Spanish bat populations.

Authors:  Jordi Serra-Cobo; Blanca Amengual; Carlos Abellán; Hervé Bourhy
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

3.  Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives.

Authors:  J Schatz; B Ohlendorf; P Busse; G Pelz; D Dolch; J Teubner; J A Encarnação; R-U Mühle; M Fischer; B Hoffmann; L Kwasnitschka; A Balkema-Buschmann; T C Mettenleiter; T Müller; C M Freuling
Journal:  Epidemiol Infect       Date:  2013-09-06       Impact factor: 4.434

4.  Insights into persistence mechanisms of a zoonotic virus in bat colonies using a multispecies metapopulation model.

Authors:  Margarita Pons-Salort; Jordi Serra-Cobo; Flora Jay; Marc López-Roig; Rachel Lavenir; Didier Guillemot; Véronique Letort; Hervé Bourhy; Lulla Opatowski
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

5.  Longitudinal survey of two serotine bat (Eptesicus serotinus) maternity colonies exposed to EBLV-1 (European Bat Lyssavirus type 1): Assessment of survival and serological status variations using capture-recapture models.

Authors:  Emmanuelle Robardet; Christophe Borel; Marie Moinet; Dorothée Jouan; Marine Wasniewski; Jacques Barrat; Franck Boué; Elodie Montchâtre-Leroy; Alexandre Servat; Olivier Gimenez; Florence Cliquet; Evelyne Picard-Meyer
Journal:  PLoS Negl Trop Dis       Date:  2017-11-17

6.  Antibodies against Lagos bat virus in megachiroptera from West Africa.

Authors:  David T S Hayman; Anthony R Fooks; Daniel Horton; Richard Suu-Ire; Andrew C Breed; Andrew A Cunningham; James L N Wood
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

7.  European bat lyssavirus in Scottish bats.

Authors:  Sharon M Brookes; James N Aegerter; Graham C Smith; Derek M Healy; Tracey A Jolliffe; Susan M Swift; Iain J Mackie; J Stewart Pritchard; Paul A Racey; Niall P Moore; Anthony R Fooks
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

8.  Endemic circulation of European bat lyssavirus type 1 in serotine bats, Spain.

Authors:  Sonia Vázquez-Morón; Javier Juste; Carlos Ibáñez; Eduardo Ruiz-Villamor; Ana Avellón; Manuel Vera; Juan E Echevarría
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

9.  Variability in seroprevalence of rabies virus neutralizing antibodies and associated factors in a Colorado population of big brown bats (Eptesicus fuscus).

Authors:  Thomas J O'Shea; Richard A Bowen; Thomas R Stanley; Vidya Shankar; Charles E Rupprecht
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  European bat lyssaviruses: Distribution, prevalence and implications for conservation.

Authors:  S L Harris; S M Brookes; G Jones; A M Hutson; P A Racey; J Aegerter; G C Smith; L M McElhinney; A R Fooks
Journal:  Biol Conserv       Date:  2006-06-06       Impact factor: 5.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.